Common use of Agency Contacts Clause in Contracts

Agency Contacts. For questions about program issues contact: Xxxxxxxx X. Xxxxxxxxx, PsyD Public Health Advisor Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 6-1132 Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. For questions about program issues contact: Xx. Xxxxxxxx X. XxxxxxxxxXxxxxx Suicide Prevention Branch Division of Prevention, PsyD Public Traumatic Stress & Special Programs Center for Mental Health Advisor Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 6000-1132 Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx xxxxxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx XXXXXXX@xxxxxx.xxx.xxx Appendix I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. For questions about program issues contact: Xxxxxxxx X. XxxxxxxxxXxxxx Xxxxxxxxxx Deputy Chief Child, PsyD Public Adolescent and Family Branch Center for Mental Health Advisor Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 6-1132 0000 Xxxxxxx Xxxx, 00X00X Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx Xxxxx.xxxxxxxxxx@xxxxxx.xxx.xxx Xxxxx Xxxxxx Public Health Advisor/Government Project Officer Child, Adolescent, and Family Branch Center for Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxx Xxxx, 14N06B Rockville, MD 20857 (000) 000-0000 xxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx XXXXXXX@xxxxxx.xxx.xxx Appendix I A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xxxxxxxx Xxxxx X. XxxxxxxxxXxxx, PsyD Public Health Advisor MPH Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx 0000 Xxxxxxx Xxxx, Xxxx Room 6-1132 00X00X Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Xxxxxx Xxxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx XXXXXXX@xxxxxx.xxx.xxx Appendix I A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Guidelines‌ Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. ‌ For questions about program issues contact: Xx. Xxxxxxxx X. XxxxxxxxxXxxxxx Suicide Prevention Branch Division of Prevention, PsyD Public Traumatic Stress & Special Programs Center for Mental Health Advisor Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 6000-1132 Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx xxxxxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx XXXXXXX@xxxxxx.xxx.xxx Appendix I A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Guidelines‌ Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. For questions about program issues contact: Xxxxxxxx X. XxxxxxxxxXxxxx Xxxxxx, PsyD Public LCPC Suicide Prevention Branch, Division of Prevention, Traumatic Stress and Special Programs Center for Mental Health Advisor Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx, Xxxx Room 60-1132 0000 Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx Xxxxx.xxxxxx@xxxxxx.xxx.xxx Xxxxx X. Xxxxxxx, Ph.D. Emergency Mental Health & Traumatic Stress Services Branch, Division of Prevention, Traumatic Stress and Special Programs Center for Mental Health Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx, Xxxx 0-0000 Rockville, MD 20857 000-000-0000 xxxxx.xxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx, Xxxx Room 70-1091 0000 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. For questions about program issues contact: Xxxxxxxx Xxxxx X. XxxxxxxxxXxxx, PsyD Public Health Advisor MPH Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx 0000 Xxxxxxx Xxxx, Xxxx Room 6-1132 00X00X Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx Phone (000) 000-0000 Fax xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxxxxx Xxxxxxx, MA Division of State Programs Center for Substance Abuse Prevention Substance Abuse and Mental Health Services Administration 0000 Xxxxxxx Xxxx, Xxxx 00X00X Rockville, MD 20857 (000) 000-0000 Phone (000) 000-0000 Fax xxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Xxxxxx Xxxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx XXXXXXX@xxxxxx.xxx.xxx Appendix I A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. For questions about program issues contact: Xxxxxxxx X. Xxxxxxxxx, PsyD Xxxxx Xxxx Public Health Advisor Advisor/Government Project Officer Child, Adolescent and Family Branch Center for Mental Health Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx, Xxxx Room 60-1132 0000 Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx xxxxx.xxxx@xxxxxx.xxx.xxx Xxxxx Xxxxxxxxxx Deputy Chief Child, Adolescent, and Family Branch Federal Center for Mental Health Services 0 Xxxxx Xxxxxx Xxxx, Xxxx 0-0000 Rockville, Maryland 20857 (000) 000-0000 xxxxx.xxxxxxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx, Xxxx Room 70-1091 0000 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. For questions about program issues contact: Xxxxxxxx X. XxxxxxxxxXxxxx Xxxxxxxxxx Deputy Chief Child, PsyD Public Adolescent, and Family Branch Center for Mental Health Advisor Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 6-1132 0000 Xxxxxxx Xxxx, 00X00X Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx xxxxx.xxxxxxxxxx@xxxxxx.xxx.xxx OR Xxxxx Xxxxxx Public Health Advisor/Government Project Officer Child, Adolescent, and Family Branch Center for Mental Health Services Substance Abuse and Mental Health Services Administration 0000 Xxxxxx Xxxx, 14N06B Rockville, MD 20857 (240) 276- 0307 xxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 0000 Xxxxxxx Xxxx, 00X00X Rockville, Maryland MD 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx Appendix I – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.

Agency Contacts. For questions about program issues contact: Xx. Xxxxxxxx X. XxxxxxxxxXxxxxx Suicide Prevention Branch Division of Prevention, PsyD Public Traumatic Stress & Special Programs Center for Mental Health Advisor Services Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 6000-1132 Rockville, MD 20857 (000) 000-0000 XXXXXX.xxx@XXXXXX.xxx.xxx xxxxxxxx.xxxxxx@xxxxxx.xxx.xxx For questions on grants management and budget issues contact: Xxxxxxxxx Xxxxxxx Office of Financial Resources, Division of Grants Management Substance Abuse and Mental Health Services Administration 0 Xxxxx Xxxxxx Xxxx Room 7-1091 Rockville, Maryland 20857 (000) 000-0000 xxxxxxxxx.xxxxxxx@xxxxxx.xxx.xxx XXXXXXX@xxxxxx.xxx.xxx Appendix I A – Confidentiality and SAMHSA Participant Protection/Human Subjects Guidelines Confidentiality and Participant Protection: Because of the confidential nature of the work in which many SAMHSA grantees are involved, it is important to have safeguards protecting individuals from risks associated with their participation in SAMHSA projects. All applicants (including those who plan to obtain IRB approval) must address the seven elements below. If some are not applicable or relevant to the proposed project, simply state that they are not applicable and indicate why. In addition to addressing these seven elements, read the section that follows entitled “Protection of Human Subjects Regulations” to determine if the regulations may apply to your project. If so, you are required to describe the process you will follow for obtaining Institutional Review Board (IRB) approval. While we encourage you to keep your responses brief, there are no page limits for this section and no points will be assigned by the Review Committee. Problems with confidentiality, participant protection, and the protection of human subjects identified during peer review of the application must be resolved prior to funding.